Viktor Dmitriev, General Manager of the Russian Pharmaceutical Manufacturers Association (ARPM), said that the factories of foreign pharmaceutical companies continue to operate in Russia despite the pressure of sanctions. DEA News.
“The work of the factories of foreign pharmaceutical companies in Russia continues. Factories as they are, as they are <…> The only thing is that Novo Nordisk left us, but the factory remained here, it works,” said Dmitriev, adding that the decision of this company was political.
Dmitriev added that at the moment, the situation with the transport of raw materials and components has improved due to the resumption of transport links with China.
Gabriel Felbermeier, former Director of the Austrian Institute for Economic Research declarationHe said that the sanctions imposed by Western countries on Russia were not effective enough and adding drugs to the list of sanctioned goods would increase the pressure on Moscow.